Literature DB >> 22301776

A pipeline for the generation of shRNA transgenic mice.

Lukas E Dow1, Prem K Premsrirut, Johannes Zuber, Christof Fellmann, Katherine McJunkin, Cornelius Miething, Youngkyu Park, Ross A Dickins, Gregory J Hannon, Scott W Lowe.   

Abstract

RNA interference (RNAi) is an extremely effective tool for studying gene function in almost all metazoan and eukaryotic model systems. RNAi in mice, through the expression of short hairpin RNAs (shRNAs), offers something not easily achieved with traditional genetic approaches-inducible and reversible gene silencing. However, technical variability associated with the production of shRNA transgenic strains has so far limited their widespread use. Here we describe a pipeline for the generation of miR30-based shRNA transgenic mice that enables efficient and consistent targeting of doxycycline-regulated, fluorescence-linked shRNAs to the Col1a1 locus. Notably, the protocol details crucial steps in the design and testing of miR30-based shRNAs to maximize the potential for developing effective transgenic strains. In all, this 14-week procedure provides a fast and cost-effective way for any laboratory to investigate gene function in vivo in the mouse.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22301776      PMCID: PMC3724521          DOI: 10.1038/nprot.2011.446

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  28 in total

1.  Production of mice using iPS cells and tetraploid complementation.

Authors:  Xiao-Yang Zhao; Zhuo Lv; Wei Li; Fanyi Zeng; Qi Zhou
Journal:  Nat Protoc       Date:  2010-04-29       Impact factor: 13.491

2.  Minimizing the risk of reporting false positives in large-scale RNAi screens.

Authors:  Christophe J Echeverri; Philip A Beachy; Buzz Baum; Michael Boutros; Frank Buchholz; Sumit K Chanda; Julian Downward; Jan Ellenberg; Andrew G Fraser; Nir Hacohen; William C Hahn; Aimee L Jackson; Amy Kiger; Peter S Linsley; Lawrence Lum; Yong Ma; Bernard Mathey-Prévôt; David E Root; David M Sabatini; Jussi Taipale; Norbert Perrimon; René Bernards
Journal:  Nat Methods       Date:  2006-10       Impact factor: 28.547

3.  Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways.

Authors:  Dirk Grimm; Konrad L Streetz; Catherine L Jopling; Theresa A Storm; Kusum Pandey; Corrine R Davis; Patricia Marion; Felix Salazar; Mark A Kay
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

4.  Second-generation shRNA libraries covering the mouse and human genomes.

Authors:  Jose M Silva; Mamie Z Li; Ken Chang; Wei Ge; Michael C Golding; Richard J Rickles; Despina Siolas; Guang Hu; Patrick J Paddison; Michael R Schlabach; Nihar Sheth; Jeff Bradshaw; Julia Burchard; Amit Kulkarni; Guy Cavet; Ravi Sachidanandam; W Richard McCombie; Michele A Cleary; Stephen J Elledge; Gregory J Hannon
Journal:  Nat Genet       Date:  2005-10-02       Impact factor: 38.330

5.  Probing tumor phenotypes using stable and regulated synthetic microRNA precursors.

Authors:  Ross A Dickins; Michael T Hemann; Jack T Zilfou; David R Simpson; Ingrid Ibarra; Gregory J Hannon; Scott W Lowe
Journal:  Nat Genet       Date:  2005-10-02       Impact factor: 38.330

6.  Reproducible and inducible knockdown of gene expression in mice.

Authors:  Jing Yu; Andrew P McMahon
Journal:  Genesis       Date:  2006-05       Impact factor: 2.487

7.  Tissue-specific and reversible RNA interference in transgenic mice.

Authors:  Ross A Dickins; Katherine McJunkin; Eva Hernando; Prem K Premsrirut; Valery Krizhanovsky; Darren J Burgess; Sang Yong Kim; Carlos Cordon-Cardo; Lars Zender; Gregory J Hannon; Scott W Lowe
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

8.  Efficient generation of germ line transmitting chimeras from C57BL/6N ES cells by aggregation with outbred host embryos.

Authors:  Marina Gertsenstein; Lauryl M J Nutter; Tammy Reid; Monica Pereira; William L Stanford; Janet Rossant; Andras Nagy
Journal:  PLoS One       Date:  2010-06-22       Impact factor: 3.240

9.  An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo.

Authors:  Michael T Hemann; Jordan S Fridman; Jack T Zilfou; Eva Hernando; Patrick J Paddison; Carlos Cordon-Cardo; Gregory J Hannon; Scott W Lowe
Journal:  Nat Genet       Date:  2003-02-03       Impact factor: 38.330

10.  An accurate and interpretable model for siRNA efficacy prediction.

Authors:  Jean-Philippe Vert; Nicolas Foveau; Christian Lajaunie; Yves Vandenbrouck
Journal:  BMC Bioinformatics       Date:  2006-11-30       Impact factor: 3.169

View more
  90 in total

Review 1.  The retinoblastoma tumor suppressor and stem cell biology.

Authors:  Julien Sage
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

Review 2.  Preclinical mouse cancer models: a maze of opportunities and challenges.

Authors:  Chi-Ping Day; Glenn Merlino; Terry Van Dyke
Journal:  Cell       Date:  2015-09-24       Impact factor: 41.582

3.  Generation of focal mutations and large genomic deletions in the pancreas using inducible in vivo genome editing.

Authors:  Amrendra Mishra; Fatemeh Emamgholi; Zulrahman Erlangga; Björn Hartleben; Kristian Unger; Katharina Wolff; Ulrike Teichmann; Michael Kessel; Norman Woller; Florian Kühnel; Lukas E Dow; Michael P Manns; Arndt Vogel; Scott W Lowe; Anna Saborowski; Michael Saborowski
Journal:  Carcinogenesis       Date:  2020-05-14       Impact factor: 4.944

4.  Simultaneous gene editing by injection of mRNAs encoding transcription activator-like effector nucleases into mouse zygotes.

Authors:  Chunliang Li; Rong Qi; Rebecca Singleterry; Judith Hyle; Amanda Balch; Xiuling Li; Jack Sublett; Hartmut Berns; Marcus Valentine; Virginia Valentine; Charles J Sherr
Journal:  Mol Cell Biol       Date:  2014-02-24       Impact factor: 4.272

Review 5.  Omics and therapy - a basis for precision medicine.

Authors:  Joseph P Garay; Joe W Gray
Journal:  Mol Oncol       Date:  2012-03-08       Impact factor: 6.603

6.  Pten loss promotes MAPK pathway dependency in HER2/neu breast carcinomas.

Authors:  Saya H Ebbesen; Maurizio Scaltriti; Carl U Bialucha; Natasha Morse; Edward R Kastenhuber; Hannah Y Wen; Lukas E Dow; José Baselga; Scott W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

7.  Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization.

Authors:  Ana P Gomes; Didem Ilter; Vivien Low; Adam Rosenzweig; Zih-Jie Shen; Tanya Schild; Martin A Rivas; Ekrem E Er; Dylan R McNally; Anders P Mutvei; Julie Han; Yi-Hung Ou; Paola Cavaliere; Edouard Mullarky; Michal Nagiec; Sejeong Shin; Sang-Oh Yoon; Noah Dephoure; Joan Massagué; Ari M Melnick; Lewis C Cantley; Jessica K Tyler; John Blenis
Journal:  Cancer Cell       Date:  2019-09-26       Impact factor: 31.743

8.  Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS.

Authors:  Ningfei An; Saira Khan; Molly K Imgruet; Sandeep K Gurbuxani; Stephanie N Konecki; Michael R Burgess; Megan E McNerney
Journal:  Blood       Date:  2018-03-28       Impact factor: 22.113

9.  Transit-amplifying cells orchestrate stem cell activity and tissue regeneration.

Authors:  Ya-Chieh Hsu; Lishi Li; Elaine Fuchs
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

10.  Virus-mediated shRNA knockdown of Na(v)1.3 in rat dorsal root ganglion attenuates nerve injury-induced neuropathic pain.

Authors:  Omar A Samad; Andrew M Tan; Xiaoyang Cheng; Edmund Foster; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  Mol Ther       Date:  2012-08-21       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.